Properties of Immune-Privileged STO-Progenitor Cells
免疫特权 STO 祖细胞的特性
基本信息
- 批准号:7468030
- 负责人:
- 金额:$ 18.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-15 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAllogenicAnimalsAntigensAxonBiochemistryBiologicalBiological ModelsC57BL/6 MouseCD34 geneCD80 AntigensCD80 geneCell CommunicationCell DensityCell Differentiation processCell LineCellsClassComplementary DNAConditionDuct (organ) structureEmbryoEngraftmentFibrous capsule of kidneyFlow CytometryGeneticGenetic TranscriptionGerman populationGoalsGrowth FactorHaplotypesHepaticHepatocyteHomologous TransplantationHumanImageImmuneImmunityImmunofluorescence ImmunologicImmunohistochemistryImmunologicsImmunosuppressionIn VitroInbred BALB C MiceInbred F344 RatsInjuryKidneyKnock-outLabelLesionLiverMHC Class I GenesMethodsMixed Lymphocyte Culture TestModelingMolecular and Cellular BiologyMonitorMusPhenotypeProceduresPropertyProteinsRat-1RattusReagentResearchSignal TransductionSkin graftSourceSpinal CordSpinal Cord LesionsStaining methodStainsStandards of Weights and MeasuresStem cell transplantStem cellsStructureSurfaceSwiss MiceSystemTNFSF6 geneTestingTherapeutic immunosuppressionTimeTissue GraftsTransgenic MiceTransgenic OrganismsTranslatingTransplantationTransplantation ImmunologyWestern BlottingWild Type MouseXenograft procedurebasedensityextracellularimmunogenicityimmunosuppressedin vivoin vivo Modelinjuredintrahepatickidney allograftnew growthnovelpressureprogenitorstemtransplantation medicine
项目摘要
DESCRIPTION (provided by applicant): The long-term objectives of this R21 application are to characterize several key biological and immunological properties of embryonic Swiss mouse STO- and STO cell-derived (SCO) progenitor cell lines to determine the utility of these cells as novel model systems of progenitor cell differentiation and engraftment into non- immunosuppressed mammalian hosts. Intrahepatic xenografts of STO and SCO cell lines survive without immunosuppression for at least three months in either dipeptidylpeptidase IV-negative (DPPIV) German F344 rats or in their wild type DPPIV* counterparts. An EGFP-labeled SCO cell line (3(8)21-EGFP) also survives without immunosuppression for at least one month as a subcapsular renal allograft in adult C57BL/6J mice, and as a subdural xenograft in C3-lesioned spinal cords in adult F344 rats. Donor mouse STO and SCO cells display phenotypes (MHC class I+[LOW1 (H-2Kd[LOW]) / class ll-negative (l-AdH); CD80- and CD86-negative) consistent with immune privilege; they differentiate into hepatic and axon-inducing neuroglial lineages in the rat liver and lesioned rat spinal cord models in vivo, respectively, and into duct-like structures under mouse renal capsules. These novel and unexpected findings suggest the hypothesis that STO and SCO cells might provide immune-privileged pluripotential progenitor cell-like material for universal tissue grafts in non-immunosuppressed recipients. Accordingly, STO and SCD cells will be used to: 1] investigate in vitro hepatocytic progenitor cell potential; 2] investigate in vivo hepatocytic progenitor cell potential and allogeneic survival in non-immunosuppressed wild type and genetically injured knockout and transgenic H-2b mice; 3] characterize immunogenicity and antigenicity in non-immunosuppressed allogeneic mice; and, 4] delineate mechanisms of non-expression of costimulatory molecules CD80 and CD86. Standard procedures of cell and molecular biology, biochemistry, immunology, transplantation and mouse genetics will be exploited, along with real-time EGFP imaging. The properties of the donor cells and recipient models examined thus far suggest novel possibilities for developing nonhuman sources of immune privileged progenitor cells for transplantation without immunosuppression. As a result of these proposed studies, new cellular reagents will be available for new models for regenerative and transplantation medicine.
描述(由申请人提供):该 R21 申请的长期目标是表征瑞士小鼠胚胎 STO 和 STO 细胞衍生 (SCO) 祖细胞系的几个关键生物学和免疫学特性,以确定这些细胞作为祖细胞分化和植入非免疫抑制哺乳动物宿主的新模型系统的效用。在二肽基肽酶 IV 阴性 (DPPIV) 德国 F344 大鼠或其野生型 DPPIV* 大鼠中,STO 和 SCO 细胞系的肝内异种移植物在没有免疫抑制的情况下存活至少三个月。 EGFP 标记的 SCO 细胞系 (3(8)21-EGFP) 在成年 C57BL/6J 小鼠中作为被膜下同种异体肾移植物,以及在成年 F344 大鼠 C3 损伤脊髓中作为硬膜下异种移植物,在没有免疫抑制的情况下也能存活至少一个月。供体小鼠 STO 和 SCO 细胞表现出与免疫豁免一致的表型(MHC I 类+[LOW1 (H-2Kd[LOW])/II 类阴性 (l-AdH);CD80 和 CD86 阴性);它们分别在体内大鼠肝脏和受损大鼠脊髓模型中分化为肝脏和轴突诱导神经胶质细胞谱系,并在小鼠肾被膜下分化为导管样结构。这些新颖且出乎意料的发现表明,STO 和 SCO 细胞可能为非免疫抑制受体的通用组织移植物提供免疫特权的多能祖细胞样材料。因此,STO和SCD细胞将用于:1]研究体外肝细胞祖细胞潜力; 2]研究非免疫抑制野生型和基因损伤的敲除和转基因H-2b小鼠体内肝细胞祖细胞潜力和同种异体存活; 3]表征非免疫抑制同种异体小鼠的免疫原性和抗原性; 4]描绘了共刺激分子CD80和CD86的不表达机制。将利用细胞和分子生物学、生物化学、免疫学、移植和小鼠遗传学的标准程序以及实时 EGFP 成像。迄今为止检查的供体细胞和受体模型的特性表明,开发非人类来源的免疫特权祖细胞用于无免疫抑制移植的新可能性。这些拟议研究的结果是,新的细胞试剂将可用于再生和移植医学的新模型。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unexpected artifacts raise new caution in stem cell culture research.
意外的假象在干细胞培养研究中引起了新的注意。
- DOI:10.1002/hep.20013
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Leffert,HyamL;Sell,Stewart
- 通讯作者:Sell,Stewart
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HYAM L LEFFERT其他文献
HYAM L LEFFERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HYAM L LEFFERT', 18)}}的其他基金
Properties of Immune-Privileged STO-Progenitor Cells
免疫特权 STO 祖细胞的特性
- 批准号:
7193735 - 财政年份:2007
- 资助金额:
$ 18.95万 - 项目类别:
IKKbeta:Bi-Functional Regulator of Hepatocyte Proliferation
IKKbeta:肝细胞增殖的双功能调节剂
- 批准号:
7261546 - 财政年份:2007
- 资助金额:
$ 18.95万 - 项目类别:
IKKbeta:Bi-Functional Regulator of Hepatocyte Proliferation
IKKbeta:肝细胞增殖的双功能调节剂
- 批准号:
7807061 - 财政年份:2007
- 资助金额:
$ 18.95万 - 项目类别:
IKKbeta:Bi-Functional Regulator of Hepatocyte Proliferation
IKKbeta:肝细胞增殖的双功能调节剂
- 批准号:
7491634 - 财政年份:2007
- 资助金额:
$ 18.95万 - 项目类别:
IKKbeta:Bi-Functional Regulator of Hepatocyte Proliferation
IKKbeta:肝细胞增殖的双功能调节剂
- 批准号:
7624633 - 财政年份:2007
- 资助金额:
$ 18.95万 - 项目类别:
ISOLATION AND ACTION OF ADULT HEPATOCYTE MITOGENS
成人肝细胞促分裂剂的分离和作用
- 批准号:
3228673 - 财政年份:1980
- 资助金额:
$ 18.95万 - 项目类别:
ISOLATION AND ACTION OF ADULT HEPATOCYTE MITOGENS
成人肝细胞促分裂剂的分离和作用
- 批准号:
3228671 - 财政年份:1980
- 资助金额:
$ 18.95万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)